A commentary on 'Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study'

被引：0
|
作者：
Gao, Fengwei [1 ,2 ,3 ]
Zhao, Xin [4 ]
Xie, Qingyun [4 ]
Yang, Jiayin [1 ,2 ,3 ]
Wu, Hong [1 ,2 ,3 ,5 ]
机构：
[1] Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Peoples R China
[3] Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China
[4] Peoples Hosp Leshan, Dept Hepatopancreatobiliary Surg, Leshan, Peoples R China
[5] Liver Transplantat Ctr, 37 Guoxue Lane, Chengdu 610041, Sichuan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF SURGERY | 2024年 / 110卷 / 04期
关键词：
D O I：
10.1097/JS9.0000000000001052
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：2442 / 2443
页数：2
相关论文
共 50 条
  • [41] Tumor burden in patients with early and intermediate-stage hepatocellular carcinoma undergoing liver resection: a retrospective multicenter study on clinical and oncological outcomes
    Martin, David
    Smet, Heloise
    Costa, Ana Cristina Da Silva
    Halkic, Nermin
    Uldry, Emilie
    Tabrizian, Parissa
    Schwartz, Myron
    Mahamid, Ahmad
    Goumard, Claire
    Scatton, Olivier
    Perinel, Julie
    Adham, Mustapha
    Demartines, Nicolas
    Melloul, Emmanuel
    HPB, 2023, 25 (07) : 836 - 844
  • [42] Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases
    Izumoto, Hirofumi
    Hiraoka, Atsushi
    Ishimaru, Yoshihiro
    Murakami, Tadashi
    Kitahata, Shogo
    Ueki, Hidetaro
    Aibiki, Toshihiko
    Okudaira, Tomonari
    Miyamoto, Yuji
    Yamago, Hiroka
    Iwasaki, Ryuichiro
    Tomida, Hideomi
    Mori, Kenichiro
    Kishida, Masato
    Tsubouchi, Eiji
    Miyata, Hideki
    Ninomiya, Tomoyuki
    Kawasaki, Hideki
    Hirooka, Masashi
    Matsuura, Bunzo
    Abe, Masanori
    Hiasa, Yoichi
    Michitaka, Kojiro
    Kudo, Masatoshi
    ONCOLOGY, 2017, 93 : 120 - 126
  • [43] Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma
    Hung, Ya-Wen
    Lee, I-Cheng
    Chi, Chen-Ta
    Lee, Rheun-Chuan
    Liu, Chien-An
    Chiu, Nai-Chi
    Hwang, Hsuen-En
    Chao, Yee
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    LIVER CANCER, 2024, 13 (01) : 29 - 40
  • [44] Treatment Strategy for Intermediate-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization, Systemic Therapy, and Conversion Therapy
    Hatanaka, Takeshi
    Yata, Yutaka
    Naganuma, Atsushi
    Kakizaki, Satoru
    CANCERS, 2023, 15 (06)
  • [45] Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study
    Yoon, Jun Sik
    Sinn, Dong Hyun
    Lee, Jeong-Hoon
    Kim, Hwi Young
    Lee, Cheol-Hyung
    Kim, Sun Woong
    Lee, Hyo Young
    Nam, Joon Yeul
    Chang, Young
    Lee, Yun Bin
    Cho, Eun Ju
    Yu, Su Jong
    Kim, Hyo-Cheol
    Chung, Jin Wook
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    CANCERS, 2019, 11 (11)
  • [46] Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study
    Chen, Junwei
    Lai, Lisha
    Lin, Qu
    Huang, Wensou
    Cai, Mingyue
    Zhu, Kangshun
    Huang, Mingsheng
    ONCOTARGET, 2017, 8 (01) : 408 - 417
  • [47] Should transarterial chemoembolization be continued after non-response to the first two sessions for intermediate-stage hepatocellular carcinoma?
    Chen, S.
    Peng, Z.
    Chen, M.
    Feng, S-T.
    Kuang, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [48] Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma
    Shi, Zhong-Xing
    Li, Chang -Fu
    Zhao, Li-Feng
    Sun, Zhong-Qi
    Cui, Li -Ming
    Xin, Yan-Jie
    Wang, Dong-Qing
    Kang, Tan-Rong
    Jiang, Hui-Jie
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2024, 23 (04) : 361 - 369
  • [49] Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma
    ZhongXing Shi
    ChangFu Li
    LiFeng Zhao
    ZhongQi Sun
    LiMing Cui
    YanJie Xin
    DongQing Wang
    TanRong Kang
    HuiJie Jiang
    Hepatobiliary & Pancreatic Diseases International, 2024, 23 (04) : 361 - 369
  • [50] Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma
    ZhongXing Shi
    ChangFu Li
    LiFeng Zhao
    ZhongQi Sun
    LiMing Cui
    YanJie Xin
    DongQing Wang
    TanRong Kang
    HuiJie Jiang
    Hepatobiliary & Pancreatic Diseases International, 2024, (04) : 361 - 369
12345